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ABSTRACT
The pharmacokinetics of fl orfenicol were investigated in cross-bred calves treated with a single 
intravenous administration (20 mg/kg) following a single intramuscular injection of paracetamol (50 mg/kg). 
The concentration of fl orfenicol in the plasma was estimated by microbiological assay technique, using E. coli 
as the test organism. The drug reached a maximum concentration of 31.5 ± 1.45 μg/mL in the plasma at 1 min, 
and this rapidly declined to 15.6 ± 0.46 μg/mL at 30 min. It was detected in the plasma above the minimum 
inhibitory concentration up to 12 h after administration. The disposition pattern of fl orfenicol followed the 
two-compartment open model. Florfenicol was fairly distributed from the blood to the tissue compartment as 
evidenced by the moderate values of the distribution coeffi cient,  (2.23 ± 0.18 per h) and the ratio of K12 /K21 
(0.82 ± 0.1). The values of AUC and Vdarea were 54.8 ± 1.51 g/mL.h and 1.5 ± 0.06 L/kg respectively. The 
elimination half-life, MRT and total body clearance were 2.84 ± 0.07 h, 3.61 ± 0.06 h and 0.37 ± 0.01 L/kg/h, 
respectively. Florfenicol at a dose of 20 mg/kg body weight IV at 12 h interval is suffi cient to maintain T>MIC 
above 80% for bacteria with MIC values 1.0 μg/mL. The favourable pharmacokinetic profi le of fl orfenicol 
with rapid distribution, high AUC, large Vdarea and 12 h dosing interval suggest that fl orfenicol may be an 
appropriate antibacterial when prescribed with paracetamol in cross-bred calves.
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Introduction 
Florfenicol (D-threo-2,2-dichloro-N-[1-(fl uoromethyl)-2-hydroxy-2-[4-methyl sulfonyl) 
phenyl] ethyl]-acetamide) is a synthetic derivative of chloramphenicol. The clinical use of 
chloramphenicol in food-producing animals has been banned because of the serious adverse 
effects produced by its residues in human beings, including bone marrow suppression, 
aplastic anemia and hemolytic anemia (RAMACHANDRAN, 2000). Florfenicol, a 
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monofl uorinated analogue of thiamphenicol, which was approved for veterinary use 
in cattle in the USA in 1996, possesses antibacterial activity against a wide spectrum 
of bacterial strains, including enteric bacteria that are resistant to chloramphenicol and 
thiamphenicol. Florfenicol has distinct advantages over the parent drug chloramphenicol, 
it has improved antibacterial spectrum activity against some chloramphenicol resistant 
strains of bacteria (MARTEL, 1994), and unlike chloramphenicol, its use in food producing 
animals does not carry the risk of inducing aplastic anemia through residues in human 
beings (PAPICH and RIVIERE, 2001). Florfenicol has been demonstrated to be active in 
vitro and in vivo against Pasteurella hemolytica, Pasteurella multocida and Haemophilus 
somnus (LOBELL et al., 1994). It has been shown to be effi cacious in the treatment of 
bovine respiratory disease (SHIN et al., 2005), undifferentiated fever (BOOKER et al., 
1997) and bacterial meningitis in calves (DeCRAENE et al., 1997), urinary and genital tract 
infections, and bacterial infections in general. Antibacterials and analgesic drugs are used 
most frequently in multiple prescriptions and it is well documented that concurrently 
administered drugs may affect the absorption, distribution, biotransformation and excretion 
of one or both (BENET et al., 1996). The co-administration of NSAIDs with antibacterials 
has been associated with pharmacokinetic interactions in bovines (CHAUDHARY and 
SRIVASTAVA, 1999; DUMKA et al., 2008; SHARMA and UL HAQ, 2012). Paracetamol, a 
non-narcotic analgesic, antipyretic agent is routinely used in veterinary practice (BOOTH, 
1995) and has been reported to alter the disposition of oxytetracycline (MANNA et al., 
1993), cefotaxime (SHARMA and SRIVASTAVA, 1997) and levofl oxacin (DUMKA, 2007) 
in ruminants. The pharmacokinetic studies of fl orfenicol have been conducted in cattle 
(DeCRAENE et al., 1997; SOBACK et al., 1995; GILLIAM et al., 2008), horses (McKELLAR 
and VARMA, 1996), cats, dogs (PAPICH and RIVIERE, 2001; PARK et al., 2008), pigs (KIM et 
al., 2008), rabbits (KOC et al., 2009), sheep (REGNIER et al., 2013), alpacas (HOLMES et al., 
2012), and chickens (CHANG et al., 2010). 
However, there is no information available on the infl uence of simultaneously 
administered paracetamol on the pharmacokinetic behavior of fl orfenicol in animals. 
In view of the paucity of such pharmacokinetic data, the present study was undertaken 
to determine the pharmacokinetics and the appropriate dosage regimen of fl orfenicol in 
cross-bred calves after its single intravenous (iv) administration upon co-administration 
with paracetamol.
Materials and methods 
Experimental animals. The study was conducted on four male cross-bred calves 
of about one year age and weighing 80-120 kg. The animals were acclimatized to the 
experimental conditions for 2 weeks prior to the commencement of the experiment. During 
the experimental period, the animals were maintained on green fodder and wheat straw, 
and water was provided ad libitum. The average day temperature in the shed was about 
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25 0C during the experiment. The experimental protocol followed the ethical guidelines 
on the proper care and use of animals and had been approved by the institutional animal 
ethics committee. 
Drug administration. Florfenicol (RF 30%, Ranbaxy Laboratories, India) was 
administered by i.v. injection into the jugular vein of calves at the dose rate of 20 mg/kg. 
The dose of fl orfenicol used in the study was comparable to the dosage used in camel, 
sheep, goats (ALI et al., 2003; REGNIER et al., 2013), pigs (LIU et al., 2003) and cows 
(SOBACK et al., 1995). Paracetamol (Bromol, Martin and Brown Pharmaceuticals, India) 
was administered at the dose rate of 50 mg/kg, by single intramuscular injection in the 
lateral neck region immediately prior to administration of fl orfenicol.
Blood sampling. Blood samples (6 mL) were collected into heparinized glass 
centrifuge tubes by contralateral jugular venipuncture at 1, 2.5, 5, 7.5, 10, 15, 30 and 45 
min and at 1, 2, 3, 4, 6, 8, 10, 12 14 and 24 h of administration of fl orfenicol. Plasma was 
separated by centrifugation at 1300 g and stored at -20 0C until analyzed for fl orfenicol, 
which was usually done on the day after collection. 
Analytical procedure. The concentration of fl orfenicol in plasma samples was 
estimated by microbiological assay technique using Escherichia coli (MTCC 739) as the 
test organism. The test organism was cultured on antibiotic medium no. 1 at 37 0C for 24 
h, and a suspension was prepared in sterile normal saline. 20 mL of molten seed layer, 
containing bacterial suspension, was poured onto a Petri dish with the help of Cornwell 
Continuous Pipetting Device (Becton Dickinson, New Jersey, USA). Preliminary 
experiments were conducted to determine the actual amount of bacterial suspension to be 
used in the preparation of the seed layer. After solidifi cation of the media, six wells were 
punched at equal distance, with the help of a punching device (developed and standardized 
in our laboratory). The samples were thawed at room temperature and suitably diluted with 
phosphate buffer. The alternate three wells were fi lled with one plasma or urine sample 
and the remaining three wells with a reference solution of fl orfenicol (0.5 g/mL). These 
assay plates were incubated at 35 0C for 8 h. At the end of incubation, the diameter of the 
zone of inhibition of each well was measured. For each sample, 9 replicates were analyzed 
and correlated with the zone of inhibition of the reference solution. The concentration of 
fl orfenicol in the samples was calculated as g/mL of plasma. This method estimated the 
level of parent drug and its active metabolites having antibacterial activity. The assay 
could detect a minimum of 0.125 g/mL of fl orfenicol. The standard curve of fl orfenicol 
was linear between 0.125 and 2.5 g/mL drug concentration (DUMKA and SINGH, 2013).
Pharmacokinetic analysis. The pharmacokinetic parameters were calculated 
manually for each animal by the regression technique (GIBALDI and PERRIER, 1982). The 
mean pharmacokinetic variables were obtained by averaging the variables calculated for 
drug disposition after intravenous drug administration to each animal. 
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The minimum inhibitory concentration (MIC90) of fl orfenicol against most of the 
susceptible bacterial pathogens of cattle has been reported to be less than 1 μg/mL, 
including Actinobacillus,, Pasteurella, Mannheimia and Bordetella, with mean MIC values 
of 0.47-0.53 against bovine Pasteurella isolates (SHIN et al., 2005; HORMANSDORFER 
and BAUER, 1998). In the current study, a concentration of 1.0 μg/mL was considered to 
be the average MIC90 of fl orfenicol against most of the pathogens for veal.
The time for which the plasma drug levels remain above or equal to the minimal 
inhibitory concentration (MIC) value was calculated using the formula:
where T>MIC is the time interval (per cent) during which the plasma concentration 
is above or equal to the MIC values, ln is the natural logarithm, D is the proposed dose, 
Vdarea is the volume of distribution, t1/2β is the terminal elimination half-life, and DI is the 
dose interval.
Results
The mean plasma levels of fl orfenicol at different time intervals, following its 
single intravenous administration after intramuscular administration of paracetamol, are 
presented in an semilogarithmic scale in Fig. 1. The pharmacokinetics are adequately 
described by the equation: Cp = Ae-αt + Be-βt
where Cp is the plasma concentration of fl orfenicol at time t, e is the base of the 
natural logarithm, A and B are zero-time plasma concentration intercepts of the biphasic 
disposition curve and α and β are hybrid rate constants related to the slopes of the 
distribution and elimination phases, respectively.
On concomitant administration of fl orfenicol and paracetamol, the mean plasma 
concentration of fl orfenicol at 1 min following its intravenous administration was 31.5 ± 
1.45 μg/mL, which declined to 0.37 ± 0.01 μg/mL at 24 hours and the drug was detected 
above the minimum inhibitory concentration (MIC90) up to 12 h of administration. 
Various kinetic determinants that describe the distribution and elimination pattern 
of fl orfenicol, after its intravenous injection in combination with paracetamol, were 
calculated. They are presented in Table 1. 
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Fig. 1. Semilogarithmic plot of plasma concentration-time profi le of fl orfenicol following its 
single intravenous injection of 20 mg/kg body weight subsequently after a single intramuscular 
injection of paracetamol (50 mg/kg). Values are presented as mean ± SE of 5 animals. The 
data was analyzed according to two-compartment open model. A and B are zero-time plasma 
drug concentration intercepts of the regression lines of distribution and elimination phases, 
respectively. Distribution () and elimination () phases are represented by regression lines. The 
calculated points (o) of distribution phase were obtained by feathering technique. 
Table 2 shows the calculated % T>MIC for microorganisms of different susceptibilities 
to fl orfenicol for 8, 12 and 24 h dosing intervals, based on the estimated pharmacokinetic 
parameters obtained following IV injection in calves following a single intramuscular 
injection of paracetamol.
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Table 1. Pharmacokinetics of fl orfenicol (20 mg/kg) after its intravenous injection following 
single intramuscular injection of paracetamol (50 mg/kg) 
Parameter Unit Mean ± SE
A g/mL 15.9 1.31
t½ h 0.32 0.02
B g/mL 11.7 0.61
t½ h 2.84 0.07
K12/K21 Ratio 0.82 0.10
AUC g/mL.h 54.8 1.51
AUMC g/mL.h2 197.6 4.74
Vdarea L/kg 1.50 0.06
fc Ratio 0.49 0.03
P/C Ratio 1.06 0.12
Cp
o g/mL 27.6 1.05
Kel /h 0.51 0.02
ClB L/kg/h 0.37 0.01
MRT h 3.61 0.06
td h 15.1 0.39
A and B, zero-time plasma drug concentration intercepts of the regression lines of distribution and elimination 
phases, respectively;  and , distribution and elimination rate constants, respectively; t½, absorption half-life; 
t½, elimination half-life; AUC, area under the plasma concentration-time curve; AUMC, area under the fi rst 
moment of plasma concentration-time curve; Vdarea, apparent volume of distribution; fc, fraction of drug in central 
compartment; P/C, ratio of drug present in central versus peripheral compartments; Kel, fi rst order elimination 
rate constant from central compartment; ClB, total body clearance of drug; Cpº, plasma drug concentration at 
time zero after intravenous dose; MRT, mean residence time; td, total duration of pharmacological effect. 
Table 2. Calculated %T>MIC for fl orfenicol based on the estimated pharmacokinetic parameters 
obtained after IV injection 20 mg/kg body weight following single IM injection of paracetamol 





0.25 67.9 135.8 203.7
0.5 56.1 112.1 168.2
1.0 44.2 88.4 132.7
1.5 37.3 74.6 111.9
2.0 32.4 64.8 97.2
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Discussion
The evaluation of the results on the observed plasma levels of fl orfenicol administered 
with paracetamol indicated that the data may be best fi tted to a two-compartment open 
model. The disposition pattern of fl orfenicol has also been reported to follow the two-
compartment open model in goats, calves, camel and sheep (ALI et al., 2003; LANE et al., 
2004; DeCRAENE et al., 1997) after intravenous administration. The plasma concentration 
of fl orfenicol at 1 min was 63 fold higher than the MIC of fl orfenicol. 
The distribution half-life of fl orfenicol was 0.32 ± 0.02 h, indicating rapid distribution 
from the central to the peripheral compartments, however it was shorter than the t½ of 
0.47 ± 0.07 h obtained after administration of fl orfenicol alone in calves (DUMKA and 
SINGH, 2013). In agreement with the present fi nding, short distribution half-lives of 0.37 
h and 0.069 h have been reported following intravenous injection of fl orfenicol in pigs 
(LIU et al., 2003) and sheep (LANE et al., 2004), respectively. The excellent distribution of 
fl orfenicol in various tissues and body fl uids was refl ected by the large Vdarea of 1.50 ± 
0.06 L/Kg in the present study, but this value was lower than the Vdarea of 1.99 ± 0.16 L/
Kg after administration of fl orfenicol alone in calves (DUMKA and SINGH, 2013). A high 
value for the volume of distribution (1.86 L/Kg) was also reported for fl orfenicol in sheep 
(SHEN et al., 2004). However, the present fi nding was more than the corresponding values 
reported in rabbits (0.57 L/Kg), sheep (0.50 L/Kg) and pigs (1.2 L/Kg) for volumes of 
distribution of fl orfenicol (LIU et al., 2003; LANE et al., 2004; ABD-EL-ATY et al., 2004). The 
excellent tissue penetration of fl orfenicol was also refl ected by the high P/C ratio in the 
present study (1.06 ± 0.12), however this value was lower than the P/C ratio of 1.55 ± 
0.19 following administration of fl orfenicol alone in calves (DUMKA and SINGH, 2013). 
The present fi nding is supported by the attainment of a high lacrimal fl uid-to-plasma 
concentration ratio of 32.5 to 40.2% after extravascular administration of fl orfenicol in 
ewes (REGNIER et al., 2013).
Consistent with the high AUC of fl orfenicol in calves (54.8 ± 1.51 g/mL.h) observed 
in the present study, which was higher than the AUC of 40.3 ± 1.70 g/mL.h after 
administration of fl orfenicol alone in calves (DUMKA and SINGH, 2013), high values of 
AUC of fl orfenicol have also been reported, such as 51.83 g/mL.h in alpacas (HOLMES 
et al., 2012), 64.86 g/mL.h in pigs (LIU et al., 2003), 76.31 and 62.45 g/mL.h in sheep 
(SHEN et al., 2004; ALI et al., 2003), 60.61 g/mL.h in camels and 74.07 g/mL.h in goats 
(ALI et al., 2003). 
The elimination half-life of fl orfenicol administered with paracetamol in calves in 
the present study (2.84 ± 0.07 h) was similar to the t½ of 2.76 ± 0.16 h obtained after 
administration of fl orfenicol alone in calves (DUMKA and SINGH, 2013), indicating the 
rapid elimination of the drug from the body. Comparable values for elimination half-
lives of fl orfenicol were reported in sheep (1.01 h), calves (3.2 h) and pigs (2.91 h) 
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following a single intravenous dose (DeCRAENE et al., 1997; LIU et al., 2003; LANE et al., 
2004). The total body clearance of fl orfenicol in calves (0.37 ± 0.01 L/Kg/h), although 
lower than the ClB of 0.50 ± 0.018 following administration of fl orfenicol alone in calves 
(DUMKA and SINGH, 2013), was higher than the values reported for ClB of 0.162 L/Kg/h 
in cattle (SOBACK et al., 1995), 0.26 L/Kg/h in sheep (SHEN et al., 2004), 0.33 L/Kg/h 
in camels (ALI et al., 2003) and 0.172 L/Kg/h in calves (ADAMS et al., 1987). The MRT 
(3.61 ± 0.06 h) of fl orfenicol obtained in present study was higher than 2.93 ± 0.059 h 
following administration of fl orfenicol alone in calves (DUMKA and SINGH, 2013) and 
the values of MRT reported in calves camels, sheep, goats and rabbits. The values of 
MRT reported in camels, sheep, goats and rabbits were 2.71 ± 0.31 h, 2.34 ± 0.25 h, 
2.11 ± 0.23 h and 1.69 h, respectively (ALI et al., 2003; ABD-EL-ATY et al., 2004). The 
alterations in the pharmacokinetic parameters of t½, Vdarea, P/c ratio, AUC, t½ , ClB and 
MRT observed in the present study from the corresponding values of these variables 
obtained after administration of fl orfenicol alone in calves may be due to the infl uence 
of co-administration of paracetamol on the pharmacokinetic constants of IV fl orfenicol. 
The fi ndings of the present study are supported by the reports whereby simultaneous 
administration of paracetamol altered the disposition of levofl oxacin and ceftizoxime in 
cross bred calves (DUMKA, 2007; SINGH et al., 2008). Further, similar alterations in the 
pharmacokinetics of levofl oxacin and gatifl oxacin were found upon co-administration of 
another NSAID, meloxicam in bovines (DUMKA et al., 2008 and 2010).
Florfenicol acts as a time-dependent bactericidal drug. The most important 
pharmacodynamic/pharmacokinetic parameter for this type of drug is the length of the 
time during which drug remains above the MIC90 value. It is generally recommended that 
T>MIC should be at least 50% of the dosage interval to ensure an optimal bactericidal 
effect (TOUTAIN and LEES, 2004). The purpose of the present study was to calculate and 
modify the dosage regimen of fl orfenicol for concomitant administration with paracetamol 
in cross-bred calves. The experimental data presented here shows that fl orfenicol at a 
dose of 20 mg/kg body weight IV at 12 h interval is suffi cient to maintain T>MIC above 
80% for bacteria with MIC values 1.0 μg/mL and above 60% for bacteria with MIC 
values  2.0 μg/mL. This dosage regimen meets the pharmacokinetic-pharmacodynamic 
criteria predicting a successful therapy for susceptible bacteria with MIC 2.0 μg/mL. The 
favourable pharmacokinetic profi le of fl orfenicol with rapid distribution, high AUC, large 
Vdarea and 12 h dosing interval suggest that fl orfenicol may be an appropriate antibacterial 
when prescribed with paracetamol in cross-bred calves.
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SAŽETAK
Istraživana je farmakokinetika jednokratno intravenski primijenjenog fl orfenikola (20 mg/kg) u križane 
teladi nakon jednokratne intramuskularne primjene paracetamola (50 mg/kg). Koncentracija fl orfenikola 
u plazmi bila je procijenjena mikrobiološkim testom uporabom bakterije E. coli kao testiranog organizma. 
Lijek je dosegao maksimalnu koncentraciju od 31,5 ± 1,45 μg/mL u plazmi za jednu minutu da bi se njegova 
koncentracija vrlo brzo, već za 30 minuta, spustila na 15,6 ± 0,46 μg/mL, a potom se u plazmi nalazio iznad 
minimalne inhibicijske koncentracije do 12 sati nakon primjene. Dispozicija fl orfenikola odvijala se po modelu 
dvostrukog odjeljka. Florfenikol se lako proširio iz krvi u tkiva što je dokazano na osnovi umjerenih vrijednosti 
koefi cijenta raspodjele,  (2,23 ± 0,18 na sat) i omjera K12/K21 (0,82 ± 0,1). Vrijednost AUC iznosila je 54,8 ± 
1,51 g/mL/h, a Vdpovršine 1,5 ± 0,06 L/kg. Poluživot izlučivanja iznosio je 2,84 ± 0,07 h, MRT 3,61 ± 0,06 h, 
a sveukupni tjelesni klirens 0,37 ± 0,01 L/kg/h. Intravenska primjena fl orfenikola u dozi od 20 mg/kg tjelesne 
mase u razmaku od 12 sati dovoljna je za održavanje T>MIC iznad 80% za bakterije s vrijednostima minimalne 
inhibicijske koncentracije MIC 1,0 μg/mL. Povoljan farmakokinetički profi l fl orfenikola s brzom raspodjelom, 
visokim AUC, širokim Vdpovršine i 12 h intervalom doziranja pokazuje da on može imati odgovarajući 
antibakterijski učinak u križane teladi kada se primjenjuje s paracetamolom. 
Ključne riječi: telad, doziranje, fl orfenikol, paracetamol, farmakokinetika ________________________________________________________________________________________
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